Business
Press Release Jun 15 2021
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 15, 2021, titled "Glenmark launches Tiogiva��, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 15, 2021, titled \"Glenmark launches Tiogiva��, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler\". View Attachment","length":416,"tagName":"div"}]